# Memantine in Adult Autism Spectrum Disorder

> **NCT01078844** · NA · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 4 (actual)

## Conditions studied

- Autism
- Asperger's Disorder
- Pervasive Developmental Disorder NOS

## Interventions

- **DRUG:** memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01078844
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Sponsor withdrew funds
- **Last updated:** 2017-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078844, "Memantine in Adult Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01078844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*